Carol Powers, DO
Obstetrics · Flint, MINPI 1649378738
Payments from drug & device makers
Across 693 payments — averaging $471.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$319K
- Coloplast$2K
- AbbVie$1K
- Sumitomo Pharma America, Inc.$656
- Myovant Sciences Inc.$509
- Caldera Medical, Inc$416
- plus $4K from 32 others
What the payments were for
- Speaking & faculty fees$67,00020%
- Travel & lodging$15,5005%
- Food & beverage$23,1877%
- Education$220,98268%
- Gifts$3160%
- Entertainment$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 358 | $318,662 |
| Coloplast | 27 | $1,631 |
| AbbVie(2 entities) | 80 | $1,425 |
| Sumitomo Pharma America, Inc. | 24 | $656 |
| Myovant Sciences Inc. | 38 | $509 |
| Caldera Medical, Inc | 5 | $416 |
| Astellas Pharma US Inc | 14 | $373 |
| Pfizer | 16 | $260 |
| Biogen | 10 | $259 |
| Hologic Sales And Service, LLC | 9 | $256 |
| Exeltis, USA Inc. | 15 | $253 |
| Aspira Women's Health Inc | 5 | $216 |
| Mayne Pharma Commercial LLC | 10 | $197 |
| Organon | 10 | $190 |
| Medtronic | 4 | $159 |
| Minerva Surgical, Inc | 3 | $148 |
| Therapeuticsmd, Inc. | 8 | $126 |
| Conmed Corporation | 3 | $114 |
| Bard Peripheral Vascular, Inc. | 1 | $107 |
| Coopersurgical, Inc. | 7 | $105 |
| Bayer | 6 | $102 |
| Medicem Inc. | 1 | $100 |
| Femselect Inc. | 1 | $94 |
| Smith+Nephew | 3 | $83 |
| Millicent US Inc | 4 | $78 |
| Agile Therapeutics, Inc. | 4 | $67 |
| Boston Scientific | 3 | $56 |
| Vertex | 2 | $51 |
| Avion Pharmaceuticals | 3 | $51 |
| Ascend Therapeutics US, LLC | 3 | $47 |
| Shield Therapeutics Inc | 3 | $45 |
| Mylan Pharmaceuticals Inc. | 3 | $42 |
| Zyla Life Sciences, Inc. | 3 | $37 |
| AMAG Pharmaceuticals, Inc. | 2 | $30 |
| Channel Medsystems, Inc. | 1 | $23 |
| Merck | 2 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$295,944
- DA VINCI SP$19,039
- RESTORELLE$1,108
- Desara$318
- MYFEMBREE$125
- Vertessa$111
- Venclose Maven Catheter$107
- FEMALE INCONTINENCE$100
How this compares
$327,022 in reported general payments places this provider in the 95th percentile of 48 obstetrics providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 19 | $8,799 |
| IntrarosaPrasterone (Dhea) | 18 | $4,693 |
| Estradiol | 79 | $3,339 |
| OsphenaOspemifene | 11 | $2,696 |
| Solifenacin Succinate | 15 | $2,225 |
| Clobetasol Propionate | 71 | $1,639 |
| ValacyclovirValacyclovir Hcl | 14 | $625 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $622 |
| Medroxyprogesterone Acetate | 24 | $212 |
| Ibuprofen | 16 | $45 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $42 |
| Ciprofloxacin Hcl | 15 | $41 |
| Misoprostol | 31 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $260 | $8,79919 claims |
| AMAG Pharmaceuticals, Inc.Intrarosa | $30 | $4,69318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 48 obstetrics providers in Michigan.
Other obstetrics in Flint
- Alexey LevashkevichFlint$23K
- Richard ElsworthFlint$17K
- Anton StrocelFlint$1K
- Ahmed AbdullahFlint$1K
- Katherine DammAnn Arbor$37K
- Breanna PondMarquette$18K
- Salvatore FinazzoTrenton$13K
- Jack ParksMuskegon$10K
- Joseph PrezzatoFarmington Hills$5K
- Duane KreilDearborn$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.